Onkos Surgical this week announced it received FDA de novo approval for its antibacterial coated implants. According to the Parsippany, N.J.-based company, bacterial contamination of a permanent implant could have devastating effects in orthopedic oncology and revision arthroplasty. “Implant contamination is a growing concern to the orthopaedic surgical community,” Dr. Steven Gitelis, chief medical officer, […]
Onkos Surgical
Orthobond wins FDA de novo approval for antibacterial technology that could have vast device applications
Orthobond has secured FDA de novo approval for its Ostaguard antibacterial technology that could one day be used for a wide range of medical devices — and beyond medtech. The Monmouth Junction, New Jersey-based device developer says it’s the first time the FDA has granted a de novo request for a non-eluting coating designed to […]
Onkos wins FDA clearance for 3D-printed pelvic reconstruction system
Onkos Surgical announced today that the FDA has cleared its My3D personalized pelvic reconstruction system. My3D expands Onkos Surgical’s portfolio to include systems to treat pelvic conditions. The Parsippany, New Jeresey–based company said My3D includes 3D-printed implants, instruments and models. There is also an advanced planning service to treat deformity, trauma, disease and revisions. There […]
Onkos Surgical raises $26.5M
Surgical oncology device maker Onkos Surgical today filed an amendment to an SEC Form D confirming the sale of $26.5 million in equity. The equity offering had its first sale on Aug. 31, 2021 and today reached $26,500,001. That leaves no amount remaining to be sold. According to the amended SEC Form D, 16 investors […]
Onkos Surgical to acquire Stryker’s Juvenile Tumour System
Onkos Surgical announced today that it agreed to acquire the Juvenile Tumour System (JTS) from Stryker (NYSE:SYK). Parsippany, New Jersey–based Onkos entered into a definitive agreement with the orthopedic technology giant over the system designed to enable limb stabilization and growth in pediatric patients affected by bone cancers, severe arthropathy, severe trauma, revisions, oncology and […]
Onkos Surgical wins FDA clearance for BioGrip 3D-printed implant
Onkos Surgical today announced that it received FDA 510(k) clearance for its BioGrip 3D-printed implant technology. The Parsippany, N.J.–based company designed BioGrip to address the clinical challenge of aseptic loosening in musculoskeletal oncology and complex orthopedic limb salvage surgery. It helps provide bone ingrowth at the bone-implant interface. Get the full story on our sister […]
Onkos Surgical launches Eleos Proximal Tibia
Onkos Surgical today said it has launched its new Eleos Proximal Tibia with BioGrip technology. The implant is designed for use in complex tumor and orthopedic reconstructive procedures. It is touted as the first FDA cleared, 3D printed limb salvage replacement. “The new Eleos Proximal Tibia with BioGrip offers features that are intended to help […]
Onkos Surgical raises $7.6m
Surgical oncology device developer Onkos Surgical filed an SEC Form D to confirm the sale of nearly $7.6 million in equity. The Parsippany, N.J.-based company made its first sale for the new notice on April 21, having now sold approximately $7.57 million. The total offering amount is $12 million, leaving more than $4.4 million remaining […]
Onkos Surgical launches bone scaffolding technology
Onkos Surgical recently launched its GenVie Magnesium Bone Scaffold. The GenVie is a magnesium-based bone void filler with osteoconductive and high compression strength attributes to promote bone repair and regeneration. It is designed for surgically created osseous defects or osseous defects created from traumatic injury to the bone. “We are excited about the launch of […]
Onkos Surgical partners with Integrum for OPRA Implant System
Onkos Surgical this week announced it signed a multi-year agreement with Integrum to expand to market for Integrum’s OPRA Implant System. The collaboration is expected to commence immediately and will focus on expanding the U.S. market for Integrum’s Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System. “We are delighted to partner with Dr. […]
Bone Solutions, Onkos ink private label deal
Bone Solutions said today that it entered into a private label licensing agreement with Onkos Surgical for its OsteoCrete bone void-filling technology. Colleyville, Texas-based BSI’s OsteoCrete is an FDA 510(k)-cleared magnesium-based injectable, moldable solution designed to attaching ligaments and tendons to bone and bone to bone. Parsippany, N.J.-based Onkos Surgical intends to market OsteoCrete under the […]
